Two Months of Therapy: A Case of Pathologic Complete Response to Chemoimmunotherapy in a Patient With Metastatic Colorectal Cancer

被引：3
|
作者：
Armstrong, Samantha [1 ]
Al-Ghawi, Hayma [2 ]
Helft, Paul [3 ]
House, Michael G. [4 ]
Spittler, Aaron J. [5 ]
Wu, Howard H. [6 ]
Shahda, Safi [7 ]
机构：
[1] Indiana Univ Sch Med, Dept Internal Med, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Cytopathol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Dept Med, Melvin Bren Simon Canc Ctr, Indianapolis, IN USA
[4] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[5] Indiana Univ, Melvin Bren Simon Canc Ctr, Clin Res, Indianapolis, IN 46204 USA
[6] Indiana Univ Sch Med, Dept Clin Pathol & Lab Med, Indianapolis, IN 46202 USA
[7] Indiana Univ, Melvin Bren Simon Canc Ctr, Dept Clin Med, Indianapolis, IN 46204 USA
来源：
CLINICAL COLORECTAL CANCER | 2018年 / 17卷 / 02期
关键词：
Immunotherapy; Lynch syndrome; Mismatch repair; PD-1; inhibitors; MICROSATELLITE INSTABILITY; BLOCKADE; PD-1;
D O I：
10.1016/j.clcc.2017.12.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E229 / E232
页数：4
相关论文
共 50 条
  • [21] Adjuvant Immunotherapy Should Not be Used in Patients With a Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy
    Phillips, William J.
    Camidge, Ross
    Wheatley-Price, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (01) : 30 - 33
  • [22] IMPROVED SURVIVAL OF PATIENTS WITH METASTATIC COLORECTAL CANCER BY A CHEMOIMMUNOTHERAPY PROGRAM
    VALDIVIESO, M
    MAVLIGIT, GM
    BURGESS, AM
    BODEY, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 301 - 301
  • [23] Importance of Complete Pathologic Response to Prehepatectomy Chemotherapy in Treating Colorectal Cancer Metastases
    Tanaka, Kuniya
    Takakura, Hideki
    Takeda, Kazuhisa
    Matsuo, Kenichi
    Nagano, Yasuhiko
    Endo, Itaru
    ANNALS OF SURGERY, 2009, 250 (06) : 935 - 942
  • [24] Case of complete response to neoadjuvant therapy using nivolumab in a patient with metastatic renal cell carcinoma
    Ikarashi, Daiki
    Kato, Yoichiro
    Katagiri, Hirokatsu
    Takahara, Takeshi
    Uesugi, Noriyuki
    Shiomi, Ei
    Sugimura, Jun
    Nitta, Hiroyuki
    Sugai, Tamotsu
    Obara, Wataru
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (06) : 630 - 632
  • [25] Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer
    Singh, Balraj
    Kaur, Parminder
    Gupta, Sachin
    Guragai, Nirmal
    Maroules, Michael
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2021, 9
  • [26] Complete Metabolic Response Is Not Uniformly Predictive of Complete Pathologic Response After Induction Therapy for Esophageal Cancer
    Stiles, Brendon M.
    Salzler, Gregory
    Jorgensen, Anna
    Nasar, Abu
    Paul, Subroto
    Lee, Paul C.
    Port, Jeffrey L.
    Altorki, Nasser K.
    ANNALS OF THORACIC SURGERY, 2013, 96 (05): : 1820 - 1825
  • [27] Is There a Pattern for Pathologic Complete Response in Gastric Cancer Undergoing Neoadjuvant Therapy?
    Schaefer, Kenzie L.
    Brown, Sacha D.
    Hsu, Chiu-Hsieh
    Khreiss, Mohammad
    Riall, Taylor S.
    Arrington, Amanda K.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S238 - S238
  • [28] Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report
    He, Yong-Gang
    Wang, Zheng
    Li, Jing
    Xi, Wang
    Zhao, Chong-Yu
    Huang, Xiao-Bing
    Zheng, Lu
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (11)
  • [29] Complete Pathologic Response to Neoadjuvant Chemoimmunotherapy and Oxaliplatin-Induced Fever Associated With IL-6 Release in a Patient With Locally Advanced Colon Cancer
    Copur, Mehmet Sitki
    Schroeder, Caleb
    Ly, Quan
    Wedel, Whitney
    Kelly, Jacqueline R.
    Rodriguez, Paul
    Tun, Soe Min
    Lintel, Nicholas
    Horn, Adam
    Riley, Bronson
    ONCOLOGY-NEW YORK, 2022, 36 (02): : 115 - 119
  • [30] Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
    Jones, M. R.
    Schrader, K. A.
    Shen, Y.
    Pleasance, E.
    Ch'ng, C.
    Dar, N.
    Yip, S.
    Renouf, D. J.
    Schein, J. E.
    Mungall, A. J.
    Zhao, Y.
    Moore, R.
    Ma, Y.
    Sheffield, B. S.
    Ng, T.
    Jones, S. J. M.
    Marra, M. A.
    Laskin, J.
    Lim, H. J.
    ANNALS OF ONCOLOGY, 2016, 27 (05) : 801 - 806
12345